-->
Sharechat Logo

Macquarie sells 15.6% stake in Oceania Healthcare for $104.5M

Thursday 6th September 2018

Text too small?

Oceania Healthcare's cornerstone shareholder Macquarie Group sold a 15.6 percent stake in the aged care and retirement village operator for $104.5 million, reducing its holding to 41.7 percent.

Oceania Healthcare Holdings Ltd, the investment vehicle which owns the shares on behalf of Macquarie Group managed funds and senior managers, sold 95 million shares at $1.10 apiece in a bookbuild process to a range of New Zealand and Australian institutional investors, and New Zealand retail investors, according to a statement to the NZX. 

The shares will resume trading today after being halted yesterday while Deutsche Craigs, Craigs Investment Partners, First NZ Capital and Macquarie Securities managed the sale, which was underwritten at $1.08 a share. The stock last traded at $1.14, having risen 13 percent over the past year. 

Oceania Healthcare's shares are rated a 'hold', according to analysts polled by Reuters, with a mean target price of $1.19. The shares were sold in an initial public offer last year at 79 cents.

Under the conditions outlined in the offer, restrictions on the Macquarie stake were lifted on July 27, after Oceania reported its 2018 annual result. The Macquarie sell down means it will no longer be able to control the appointment of any directors to the board.

(BusinessDesk)

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

MYOB adds 57% more subscribers in 2018 but total online customers still lag Xero's
Investors fear chilling effect as former IRD boss opposes capital gains proposals
Stuff 1H earnings slide but Nine still optimistic of finding buyer
NZ Post achieves first-half revenue growth for the first time since 2015
TeamTalk affirms annual earnings guidance as rising costs dent first-half profit
Government to step up efforts as second Queensland fruit fly detected
Spark's Moutter bangs drum for 5G spectrum auction
F&P Healthcare and ResMed drop patent infringement disputes
NZ dollar dips after Fed minutes not as dovish as expected
February 21st Morning Report

IRG See IRG research reports